COVAX > Clinical Development and Operation > Maternal Immunization > Key Deliverables

Key Deliverables

V.1 Vaccine candidate mapping, key characteristics, and development timelines

COVID-19 Vaccines prioritized by COVAX  | Vaccine Candidate Mapping  | Target Product Profile  

V2. Key questions for the evaluation of COVID-19 vaccine candidates in pregnant and lactating women 

V.3 Key Questions for the post-licensure safety evaluation of COVID-19 vaccine candidates in pregnant and lactating women.


The MIWG regularly issues reports summarizing its activities in the respective period. These can be accessed from the below links.

COVAX Maternal Immunization Working Group Project Report | March 2021

COVAX Maternal Immunization Working Group Executive Summary Report | January 2021

Workshop materials

THE MIWG is holding workshops on pertinent topics as and when needed. They are typically announced in the SWAT Teams newsletter. Workshop material and reports are available below.

  • Advances in maternal immunization science and implementation in times of COVID-19 - How has the COVID-19 pandemic impacted the future of maternal immunization? | 18 November 2021 | Workshop Material | Workshop Report

  • Expert Consultation on Post-Vaccine Thrombosis Thrombocytopenia Syndrome & Impact on Maternal Immunization | 9 June 2021 | Workshop material Workshop Report

  • Challenges of vaccinating pregnant and lactating women during the COVID-19 pandemic | 13 Apr 2021 | Workshop Material Workshop Report

  • Accelerating Access to COVID-19 Vaccine for Pregnant and Lactating Women – What do Developers Need to Know?  | 16 Dec 2020 | Workshop Report

  • CEPI workshop on Maternal Immunization against Emerging Infectious Diseases | London 12-13 Feb 2020 | Workshop Report